Biocryst Pharmaceuticals (BCRX) Capital Expenditures (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted Capital Expenditures of $209,000 for Q2 2026, up 16.8% from $179,000 a year earlier but down 48.1% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Capital Expenditures (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Biocryst Pharmaceuticals was $2.76 million, up 161.2% year-over-year; for FY2025, it came in at $2.47 million, up 119.6% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 36.9% (FY2020 to FY2025).
- In prior years, Biocryst Pharmaceuticals' Capital Expenditures was $1.12 million in FY2024 (-48.2%), $2.17 million in FY2023 (+60.5%), $1.35 million in FY2022 (-43.4%) and $2.39 million in FY2021 (+364.0%).
- Quarterly Capital Expenditures has run from a low of $59,000 in Q3 2024 to a high of $1.34 million in Q3 2025 over five years.
- On a year-over-year basis, Capital Expenditures has increased in each of the last three quarters, with growth averaging 17.4% over the last seven quarters.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q4 2021, with growth of 614.8%; the weakest was Q3 2024, with a decline of 94.0%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $403,000 (Q1 2026), $802,000 (Q4 2025) and $1.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn | 209,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 209,000.00 |
| Mar 31, 2026 | 403,000.00 |
| Dec 31, 2025 | 802,000.00 |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 179,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Dec 31, 2024 | 675,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 155,000.00 |
| Mar 31, 2024 | 235,000.00 |
| Dec 31, 2023 | 554,000.00 |
| Sep 30, 2023 | 987,000.00 |
| Jun 30, 2023 | 467,000.00 |
| Mar 31, 2023 | 160,000.00 |
| Dec 31, 2022 | 526,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 244,000.00 |
| Mar 31, 2022 | 406,000.00 |
| Dec 31, 2021 | 1.11 Mn |
| Sep 30, 2021 | 365,000.00 |
API Access
Biocryst Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();